RecruitingNot ApplicableNCT06862128

OGTT at Home Using CGM vs at the Clinic

Oral Glucose Tolerance Test at Home With Continuous Glucose Monitoring vs Standard Clinic-based Testing


Sponsor

Linkoeping University

Enrollment

75 participants

Start Date

Jun 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria6

  • Prediabetes indicated by ≥2 of the following values, measured at separate occasions or through different analyses during the past 2 years:
  • \- Fasting venous plasma glucose ≥6.1 but ≤6.9 mmol/L
  • \- Non-fasting venous plasma glucose ≥7.8 but ≤11.0 mmol/L
  • \- HbA1c ≥39 but ≤47 mmol/mol
  • Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity
  • Ability to read and respond to online instructions and questionnaires in Swedish.

Exclusion Criteria12

  • T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses:
  • \- Fasting venous plasma glucose ≥7.0 mmol/L
  • \- Non-fasting venous plasma glucose value ≥11.1 mmol/L
  • \- HbA1c ≥48 mmol/mol
  • Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery
  • Body mass index \<20 kg/m2
  • Body weight \<43 kg
  • Current pregnancy
  • Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period
  • Fear of needle sticks
  • Shift work during the study period
  • Involvement in the study design, data collection, analysis, or participant recruitment.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTOGTT at home using CGM

OGTT at home using CGM

DIAGNOSTIC_TESTOGTT at the clinic

OGTT at the clinic


Locations(3)

Primary Health Care Center Bra Liv Rosenhälsan

Huskvarna, Jönköping County, Sweden

Primary Health Care Center Cityhälsan Centrum

Norrköping, Norrköping, Sweden

Primary Care Center Vårdcentralen Kärna

Linköping, Östergötland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06862128


Related Trials